학술논문
Alectinib as first-line treatment for advanced ALK-positive non-small cell lung cancer in the real-world setting: preliminary analysis in a Chinese cohort
Document Type
Artikel
Author
Source
Translational lung cancer research. 11(12):2495
Subject
Language
English
English
English
ISSN
2218-6751